Loading…
Preclinical evaluation of new PET tracers for in vivo imaging of PD-L1 expression
Rubins, Daniel J, McQuade, Paul, Klimas, Michael, Meng, Xiangjun, Haley, Hyking, Lin, Shu-An, Getty, Krista L, Trotter, Dinko González
Published in The Journal of nuclear medicine (1978) (01.02.2018)
Get full text
Published in The Journal of nuclear medicine (1978) (01.02.2018)
Journal Article
Loading…
Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade
Sun, Michel M., Seleme, Nicolas, Chen, John J., Zekeridou, Anastasia, Sechi, Elia, Walsh, Ryan D., Beebe, Johanna D., Sabbagh, Osama, Mejico, Luis J., Gratton, Sean, Skidd, Philip M., Bellows, David A., Falardeau, Julie, Fraser, Clare L., Cappelen-Smith, Cecilia, Haines, Scott R., Hassanzadeh, Bahareh, Seay, Meagan D., Subramanian, Prem S., Williams, Zoë, Gordon, Lynn K.
Published in Journal of neuro-ophthalmology (01.12.2021)
Published in Journal of neuro-ophthalmology (01.12.2021)
Get full text
Journal Article
Loading…
Abstract 3250: B cell-produced IL-27 up-regulates PD-L1 expression in the tumor microenvironment to promote breast cancer development
Yan, Hui, Viswanadhapalli, Suryavathi, Chupp, Daniel, Fernandez, Maria, Wu, Shuai, Wang, Jingwei, Moroney, Justin, Taylor, Julia, Im, John, Rivera, Carlos, Luo, Yiliao, Liu, Junhao, Sareddy, Gangadhara, Casali, Paolo, Vadlamudi, Ratna, Xu, Zhenming
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Loading…
Over-Expression of Immunosuppressive Molecules, PD-L1 and PD-L2, in Ulcerative Colitis Patients
Rajabian, Zeinab, Kalani, Farzad, Taghiloo, Saeid, Tehrani, Mohsen, Rafiei, Alireza, Hosseini-Khah, Zahra, Hosseini, Vahid, Ajami, Abolghasem
Published in Iranian journal of immunology (01.03.2019)
Published in Iranian journal of immunology (01.03.2019)
Get full text
Journal Article
Loading…
Whole body PD-L1 PET in patients with NSCLC and melanoma
Leung, David K., De Langen, Joop, Raunig, David, Niemeijer, Anna-Larissa N., Smit, Egbert F., Boellaard, Ronald, Vallez-Garcia, David, Dongen, G.a.M.S. van, Windhorst, A.D., Huisman, Marc C., Glaudemans, Andor W. J. M., Hendrikse, N. Harry, Smith, Ralph Adam, Poot, Alex J., Lipovsek, Dasa, Donnelly, David J., Bonacorsi, Samuel J., Velasquez, Linda M., Du, Shuyan, Hayes, Wendy
Published in Journal of clinical oncology (10.02.2018)
Published in Journal of clinical oncology (10.02.2018)
Get full text
Journal Article
Loading…
A phase Ia/b study of TIM-3/PD-L1 bispecific antibody in patients with advanced solid tumors
Hellmann, Matthew David, Shimizu, Toshio, Doi, Toshihiko, Hodi, F. Stephen, Rottey, Sylvie, Aftimos, Philippe Georges, Tina Liu, Zhuqing, Velez de Mendizabal, Nieves, Szpurka, Anna M., Piao, Yongzhe, Vangerow, Burkhard, Gandhi, Leena, Leow, Ching Ching
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
Grywalska, Ewelina, Smarz-Widelska, Iwona, Krasowska-Zajac, Ewelina, Korona-Glowniak, Izabela, Zaluska-Patel, Karolina, Mielnik, Michal, Podgajna, Martyna, Malm, Anna, Rolinski, Jacek, Zaluska, Wojciech
Published in Archivum Immunologiae et Therapiae Experimentalis (01.04.2018)
Published in Archivum Immunologiae et Therapiae Experimentalis (01.04.2018)
Get full text
Journal Article
Loading…
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3
Rapoport, Bernardo L., Steel, Helen C., Benn, Carol A., Nayler, Simon, Smit, Teresa, Heyman, Liezl, Theron, Annette J., Hlatshwayo, Nomsa, Kwofie, Luyanda L.I., Meyer, Pieter W.A., Anderson, Ronald
Published in Frontiers in oncology (30.03.2023)
Published in Frontiers in oncology (30.03.2023)
Get full text
Journal Article
Loading…
Loading…
Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy
Tariq, Hafiza Kashaf, Liang, Zihao, Rabiu, Lawan, Ibrahim, Abdulrahman, Mohamady Farouk Abdalsalam, Nada, Li, Rong, Yang, Qiong, Wan, Xiaochun, Yan, Dehong
Published in Cells (Basel, Switzerland) (01.01.2025)
Published in Cells (Basel, Switzerland) (01.01.2025)
Get full text
Journal Article
Loading…
60 Use of the Combined Positive Score (CPS) with the companion diagnostic PD-L1 IHC 22C3 pharmDx provides precise evaluation of PD-L1 expression across multiple tumor indications and cutoffs
Ponce, Francisco, Hund, Stephanie, Peltz, Lindsay, Placa, Chris La, Vilardo, Monika, Watts, Brittany, Tabuena-Frolli, Siena, Toland, Grant, Posch, Alex, Milo, Jay, Kulangara, Karina, Apostolaki, Angeliki
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Loading…
A phase I, open, multiple dose, dose escalation and expansion study to evaluate the safety, tolerability, and pharmacokinetics of KN035 (anti-PD-L1 antibody) administered in subcutaneous injection as a single agent to Chinese subjects with advanced solid tumors
Xu, Jianming, Qin, Shukui, Zhang, Yun, Zhang, Yaoyue, Jia, Ru, Liu, Rongrui, Wang, Yan, Zhang, Gairong, Zhao, Chuanhua, Lu, Ni, Ma, Xiaoyu, He, Yue, Yuan, Liwei, Lin, Yihui, Xu, Wenlian, Wang, Xiaoxiao, Wang, Pilin, Xu, Ting, Dong, RuiPing, Gong, John
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Loading…
Gastric inflammatory prognostic index (GIPI) to predict efficacy of PD-1/PD-L1 immune checkpoint inhibitors in metastatic gastroesophageal junction (GOJ)/gastric cancer (GC) patients
Morelli, Cristina, Formica, Vincenzo, Patrikidou, Anna, Murias, Carmen, Butt, Sabeeh-Ur-Rehman, Nardecchia, Antonella, Lucchetti, Jessica, Renzi, Nicola, Shiu, Kai-Keen, Roselli, Mario, Arkenau, Tobias
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
Pd-l1 assessment in needle core biopsies of non-small cell lung cancer: interpathologist agreement and potential associated histopathological features
Hacihasanoglu, Ezgi, Sigirci, Buket Bambul, Usul, Gamze, Savli, Taha Cumhan
Published in Turk patoloji dergisi (01.01.2024)
Published in Turk patoloji dergisi (01.01.2024)
Get full text
Journal Article
Loading…
Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC
Shafique, Michael Rahman, Fisher, Terrence Lee, Evans, Elizabeth E., Leonard, John E., Pastore, Desa Rae Electa, Mallow, Crystal L., Smith, Ernest, Schröder, Andreas, Chin, Kevin M., Beck, Joseph Thaddeus, Baumgart, Megan Ann, Govindan, Ramaswamy, Gabrail, Nashat Y., Sanborn, Rachel E., Spira, Alexander I., Seetharamu, Nagashree, Lou, Yanyan, Mansfield, Aaron Scott, Goldman, Jonathan Wade, Zauderer, Maurice
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
Expression of PD-L1 in malignant soft tissue neoplasm and their correlation with clinicopathological parameters
Mishra, Ashutosh, Singh, Anurag, Kumar, Madhu, Sagar, Mala, Kumari, Malti, Qayoom, Sumaira, Kumar, Vijay
Published in Journal of laboratory physicians (28.07.2023)
Published in Journal of laboratory physicians (28.07.2023)
Get full text
Journal Article
Loading…
Abstract A038: Investigating PD-L1 status in circulating tumor cells isolated from blood samples of lung cancer patients
Spode, Morgan, Goodwin, Chloe, Varatharajah, Aarabhi, Cottingham, Aaron, Duhig, Elisha, Kaja, Laura, Greaves, David, Ciccioli, Mariacristina, Pailhes-Jimenez, Anne-Sophie
Published in Clinical cancer research (13.11.2024)
Published in Clinical cancer research (13.11.2024)
Get full text
Journal Article
Loading…
Loading…
Gastric Immune Prognostic Index (GIPI) in metastatic (m) gastro-oesophageal junction (GOJ)/gastric cancer (GC) patients (pts) treated with PD-1/PD-L1 immune checkpoint inhibitors (ICIs)
Morelli, Cristina, Formica, Vincenzo, Patrikidou, Anna, Murrias, Carmen, Butt, Sabeeh, Nardecchia, Antonella, Lucchetti, Jessica, Renzi, Nicola, Iannantuono, Giovanni Maria, Roselli, Mario, Shiu, Kai-Keen, Arkenau, Tobias
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
Loading…
Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma
Chen, Haiming, Li, Mingjie, Sanchez, Eric, Ng, Nicole, Yu, Erin, Bujarski, Sean, Yin, Zhengyi, Hekmati, Tara, Field, Dylan, Wang, Jasper, Nassir, Isabella, Yu, Janna, Huang, Justin, Daniely, David, Wang, Cathy S., Xu, Ning, Berenson, James R.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article